Pharmafile Logo
Pharmafocus logo
Advanced Search

Merck

Showing 15 posts of 363 posts found.

merck serono image

Merck Serono won’t give up on cancer vaccine

September 26, 2013
Sales and Marketing Merck, Merck Serono, Stimuvax

Merck Serono’s once failed lung cancer vaccine treatment Stimuvax has been given a second chance as the German firm begins …

News
merck_entrance

MSD’s sugammadex knocked back by FDA – again

September 25, 2013
Research and Development, Sales and Marketing FDA, MSD, Merck, Sugammedex

News
astrazeneca image

AstraZeneca pays Merck for cancer drug

September 11, 2013
Sales and Marketing AstraZeneca, Cancer, Merck, WEE1

AstraZeneca is to pay $50 million up front to get a worldwide licensing deal for one of Merck’s investigational drugs …

News
Merck image

Green light at Merck facility boosts varicella vaccine supplies

September 9, 2013
Manufacturing and Production Merck, Taylor, varicella

Prospects for Merck & Co’s vaccines for shingles and chickenpox have been lifted by approval of additional bulk manufacturing capacity …

News
Zostavax image

NHS shingles vaccine rolls out for people in their 70s

September 2, 2013
Sales and Marketing Merck, NHS, Zostavax, shingles

The NHS will introduce a nationwide shingles vaccination scheme this week aimed at people in their 70s. Merck’s Zostavax will …

News
merck_incweb

Merck told to make $1 billion in cuts

August 22, 2013
Sales and Marketing Leerink Swann, MSD, Merck, Odanacatib, sugammadex

News
Merck image

Merck to shut New Jersey campus, shedding 113 jobs

August 8, 2013
Manufacturing and Production Jobs, Merck, Schering-Plough, cuts

Merck & Co has followed through with an earlier threat to close down its manufacturing operations at Kenilworth, New Jersey. …

News
Merck KgAA

Merck, Hedinger first suppliers certified under excipient scheme

August 1, 2013
Manufacturing and Production Merck, Merck KGaA

Merck KGaA’s EMD Millipore unit and fellow German firm Hedinger have become the first two excipient suppliers to be certified …

News
Merck image

Merck sees sales dip

July 31, 2013
Sales and Marketing Merck, Q2, Singulair, sales

A catastrophic decline in sales of asthma medicine Singulair is among the key reasons why Merck’s pharma revenue fell 12% …

News
Merck image

MSD cleared by PMCPA

July 23, 2013
Medical Communications, Sales and Marketing ABPI, MSD, Merck, PMCPA, code

Merck Sharp Dohme has been found not guilty of breaching two clauses in the ABPI Code of Practice – including …

News
januvia image

MSD takes Januvia rap

July 9, 2013
Medical Communications, Sales and Marketing Januvia, MSD, Merck, PMCPA

Merck Sharp & Dohme has been censured by the PMCPA for failing to uphold standards in the way it promoted …

News
Merck image

Aspen buys Merck facility and products in $1 billion deal

July 1, 2013
Manufacturing and Production MSD, Merck, Oss, aspen

Africa’s largest drugmaker Aspen Pharmacare has agreed to buy a manufacturing facility owned by Merck & Co, plus a portfolio …

News

Nine fined in EU pay-for-delay deals

June 20, 2013
Manufacturing and Production, Sales and Marketing EU, Lundbeck, Merck, Ranbaxy

Nine pharma firms have been handed hefty fines by the European Commission over allegations that they willingly blocked generic versions …

News
Merck image

FDA experts recommend Merck sleep pill

May 24, 2013
Research and Development, Sales and Marketing FDA, Merck, insomnia, suvorexant

Merck received welcome news this week from the FDA after one of the US regulator’s expert groups voted to approve …

News
asdasd

Hurel appoints Schering-Plough executive to its Board

May 24, 2013
Manufacturing and Production, Research and Development, Sales and Marketing Hurel, Merck, Schering-Plough

Pre-clinical products firm Hurel has appointed Dr James MacDonald to the company’s Board of directors.  MacDonald is the former executive …

Appointment
The Gateway to Local Adoption Series

Latest content

Just – Evotec given Gates Foundation grant to increase global biotherapeutics access

January 8, 2026

Johnson & Johnson submits robotic surgical system for De Novo classification

January 8, 2026

EA Pharma announces phase 3 trial for new schizophrenia treatment in Japan

January 7, 2026

Eleva appoints Erich Rajkovic as Chief Business Officer

January 7, 2026

MedPharm announces US FDA inspection of North Carolina manufacturing facility

January 6, 2026